Episode 73
Biotech Hangout
00:00
Competition between Daiichi and Gilead in ADC Space
An analysis of the recent data from Daiichi and Astra in the ADC space, particularly in breast cancer treatment, along with the ongoing battle between Gilead and Daiichi/Astra. The chapter also highlights the importance of understanding the efficacy of the antibody itself versus the chemo payload in ADCs.
Transcript
Play full episode
